|
emetine
|
CHEBI_4781 |
[A pyridoisoquinoline comprising emetam having methoxy substituents at the 6'-, 7'-, 10- and 11-positions.] |
|
preprocalcitonin
|
COVID_0000106 |
[Preprocalcitonin is a precursor of procalcitionin hormone which is cleaved by endopeptidase. The procalcitonin forms a precursor of hormone calcitonin which is involved in calcium homeostasis.] |
|
Jakotinib hydrochloride
|
COVID_0000105 |
[Jakotinib hydrochloride is a presumed inhibitor of Janus-associated kinases. It is an investigational drug used against single-stranded RNA virus (SARS-CoV2).] |
|
gene ontology enrichment analysis
|
COVID_0000104 |
|
|
medical aspect
|
COVID_0000103 |
|
|
touching contaminated surfaces
|
COVID_0000102 |
|
|
air bronchogram
|
COVID_0000101 |
|
|
thickened alveolar septum
|
COVID_0000100 |
|
|
CCL13
|
OGG_3000006357 |
|
|
CCL8
|
OGG_3000006355 |
|
|
CCL4
|
OGG_3000006351 |
|
|
CCL5
|
OGG_3000006352 |
|
|
aloxistatin
|
CHEBI_101381 |
[An L-leucine derivative that is the amide obtained by formal condensation of the carboxy group of (2S,3S)-3-(ethoxycarbonyl)oxirane-2-carboxylic acid with the amino group of N-(3-methylbutyl)-L-leucinamide.] |
|
hemic and immune system symptom
|
SYMP_0017795 |
[Symptoms manifested in organs involved in the production of blood, including the cellular and the molecular components essential in providing defense against foreign organisms or substances] |
|
pteridine-containing compound metabolic process
|
GO_0042558 |
[The chemical reactions and pathways involving any compound containing pteridine (pyrazino(2,3-dipyrimidine)), e.g. pteroic acid, xanthopterin and folic acid.] |
|
entacapone
|
CHEBI_4798 |
[A monocarboxylic acid amide that is N,N-diethylprop-2-enamide in which the hydrogen at position 2 is substituted by a cyano group and the hydrogen at the 3E position is substituted by a 3,4-dihydroxy-5-nitrophenyl group.] |
|
O-glycan processing
|
GO_0016266 |
[The stepwise addition of carbohydrate or carbohydrate derivative residues to the initially added O-linked residue (usually GalNAc) to form a core O-glycan structure.] |
|
pneumonia
|
DOID_552 |
[A lung disease that involves lung parenchyma or alveolar inflammation and abnormal alveolar filling with fluid (consolidation and exudation). It results from a variety of causes including infection with bacteria, viruses, fungi or parasites, and chemical or physical injury to the lungs. It is accompanied by fever, chills, cough, and difficulty in breathing.] |
|
NIK/NF-kappaB signaling
|
GO_0038061 |
[The process in which a signal is passed on to downstream components within the cell through the NIK-dependent processing and activation of NF-KappaB. Begins with activation of the NF-KappaB-inducing kinase (NIK), which in turn phosphorylates and activates IkappaB kinase alpha (IKKalpha). IKKalpha phosphorylates the NF-Kappa B2 protein (p100) leading to p100 processing and release of an active NF-KappaB (p52).] |
|
Diammonium Glycyrrhizinate
|
NCIT_C102865 |
[The diammonium salt of glycyrrhizin and the active constituent in the traditional Chinese medicinal herb Glycyrrhiza uralensis (Chinese liquorice or Gan-Cao) with anti-inflammatory, antioxidant and hepatoprotective properties. Diammonium glycyrrhizinate (DG) is slowly metabolized within the cells into glycyrrhetic acid, which inhibits enzymes that control cortisol metabolism and contributes to this agent's anti-inflammatory effect. Although the exact mechanism of action remains to be fully elucidated, DG may prevent or reduce hepatotoxicity via the scavenging of free radicals. This agent also upregulates the expression of transcription coactivator PGC-1alpha and modulates hepatic enzymes such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), superoxide dismutase and glutathion peroxidase.] |